|
|
|
| Clinical Effect of Acupoint Catgut Embedding Treated by Winter Disease Summer Treatment of Traditional Medicine on Stable Chronic Obstructive Pulmonary Disease with Lung and Kidney Qi Deficiency |
| SU Ganshen, HU Fuquan, DENG Yaosheng, HUANG Jingji |
| Guigang Hospital of Traditional Chinese Medicine, Guangxi, Guigang 537100, China |
|
|
|
|
Abstract Objective: To explore the clinical effect of acupoint catgut embedding treated by winter disease summer treatment of traditional medicine on stable chronic obstructive pulmonary disease (COPD) with lung and kidney qi deficiency. Method: A total of 84 COPD patients treated in the Department of Pulmonary Diseases of Guigang Hospital of Traditional Chinese Medicine from July 2018 to August 2019 were selected, they were divided into control group and traditional Chinese medicine group according to the random number table method, with 42 cases in each group. The control group was treated with basic drug therapy + exercise lifestyle intervention, and the traditional Chinese medicine group was treated with acupoint catgut embedding for winter disease summer treatment on the basis of the control group. The treatment course was 3 years. The peripheral blood T lymphocytes, serum immunoglobulin, pulmonary function parameters [peak expiratory flow (PEF), percentage of forced expiratory volume in the first second to expected value (FEV1%pred), ratio of forced expiratory volume in the first second to forced vital capacity (FEV1/FVC%)], 6 min walking distance and the total effective rate of the two groups were compared before and after the treatment. Result: 2 cases were shed in each group, and 40 patients were eventually included in each group. Before treatment, there were no significant differences in CD3+, CD4+, CD8+, CD4+/CD8+ between the two groups (P>0.05); compared with those before treatment, CD3+, CD4+ and CD4+/CD8+ in the traditional Chinese medicine group after treatment were higher, while CD8+ was lower, CD3+, CD4+ and CD4+/CD8+ in the traditional Chinese medicine group were higher than those in the control group, and CD8+ was lower than that in the control group (P<0.05). After treatment, CD4+/CD8+ in control group was higher than that before treatment, the difference was statistically significant (P<0.05). Before treatment, there were no significant differences in serum IgA, IgG, IgM and IgE levels between the two groups (P>0.05); compared with those before treatment, IgA levels were higher and IgE levels were lower in both groups after treatment, serum IgA and IgG levels in the traditional Chinese medicine group were higher than those in the control group, while IgE levels were lower (P<0.05). After treatment, there was no significant difference in IgM between the two groups (P>0.05). After treatment, IgG in traditional Chinese medicine group was higher than that before treatment, the difference was statistically significant (P<0.05). Before treatment, there were no significant differences in PEF, FEV1%pred, FEV1/FVC% between the two groups (P>0.05); compared with those before treatment, the PEF and FEV1/FVC% levels in the traditional Chinese medicine group after treatment were higher than those before treatment, those in the traditional Chinese medicine group were higher than those in the control group (P<0.05). After treatment, FEV1%pred in both groups were higher than those before treatment, the differences were statistically significant (P<0.05). After treatment, there was no significant difference in FEV1%pred between the two groups (P>0.05). Before treatment, there was no significant difference in 6 min walking distance between the two groups (P>0.05); compared with those before treatment, the 6 min walking distance after treatment were longer in both groups, that in the traditional Chinese medicine group was longer than that in the control group (P<0.05). The total effective rate in traditional Chinese medicine group was higher than that in control group (P<0.05). Conclusion: Acupoint catgut embedding treated by winter disease summer treatment of traditional medicine in the treatment of stable chronic obstructive pulmonary disease can improve immune function and lung function, which is of obvious value for improving the therapeutic effect.
|
|
Received: 15 December 2022
|
|
|
|
|
|
|
